NEW YORK (GenomeWeb News) – AstraZeneca announced today announced a two-year collaboration with the University of Cambridge and Cancer Research UK on three preclinical and clinical oncology projects, including one focused on gaining a better understanding of the genetic makeup of a patient's cancer through their tumor DNA.

Overall, the collaboration aims to move cancer research forward by studying tumor mutations and new investigational therapies in prostate, pancreatic, and possibly other cancers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

The House of Lords in the UK approves a bill to allow mitochondrial donation.